📋 FDA Reference

Optimus 0 035 Inch PTA Balloon Dilatation Catheter

Usci Ireland

Compare similar devices

Summary: The Optimus 0.035 Inch PTA Balloon Dilatation Catheter is a medical device used for percutaneous transluminal angioplasty (PTA) procedures. It is primarily used by interventional radiologists and cardiologists to treat vascular stenosis.

FDA Clearance Information

Pathway ? 510(k)
Number ? K072156 ↗
Decision Date ? November 9, 2007
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The Optimus 0.035 Inch PTA Balloon Dilatation Catheter was cleared through the FDA 510(k) pathway on November 9, 2007. It is manufactured by Usci Ireland and classified as a Class 2 device under product code DQY.

What It Is

The Optimus 0.035 Inch PTA Balloon Dilatation Catheter is designed for use in percutaneous transluminal angioplasty procedures to dilate narrowed or obstructed blood vessels. The device consists of a balloon at the tip of a catheter that can be inflated to open up the vessel, improving blood flow. It is typically used in peripheral vascular interventions.

FDA-Cleared Indications

  • Percutaneous transluminal angioplasty of stenotic or obstructed peripheral blood vessels.
  • Treatment of vascular lesions that can be reached with a compatible 0.035-inch guidewire and balloon catheter.

Clinical Applications

  • Balloon angioplasty of narrowed peripheral arteries.
  • Endovascular treatment of peripheral arterial stenosis or obstruction.
  • Dilation of vascular lesions during image-guided peripheral vascular intervention.

Reported off-label uses

  • Balloon dilation of selected venous stenoses, such as iliac or central venous narrowing, when chosen by the treating physician.
  • Adjunctive balloon dilation during selected venous stenting procedures.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The catheter is designed for use with compatible 0.035-inch guidewires; the balloon diameter and working length must match the target vessel and lesion.
  • The device is navigated under fluoroscopic or other appropriate imaging guidance, with controlled inflation to reduce the risk of dissection, rupture or other vessel injury.
  • Patient selection should account for lesion location, vessel size, severe calcification, thrombus, tortuosity and the risk of embolization or perforation.
  • MRI safety depends on the specific catheter configuration and whether any device component remains in the patient; consult the current manufacturer labeling before MRI.
  • As a temporary angioplasty catheter, it is not intended to remain implanted. It is supplied for single use unless current labeling states otherwise.

Procedures that use this device

Frequently Asked Questions

What is the Optimus 0.035 Inch PTA Balloon Dilatation Catheter used for?

It is used for percutaneous transluminal angioplasty to dilate narrowed blood vessels and improve blood flow.

What specialties typically use this device?

Interventional radiologists and vascular surgeons typically use this device in endovascular procedures.

What are the FDA-cleared indications?

It is indicated for use in patients with vascular stenosis to help widen narrowed blood vessels.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you